Logo image of FTCH

FARFETCH LTD-CLASS A (FTCH) Stock Fundamental Analysis

NYSE:FTCH - New York Stock Exchange, Inc. - KY30744W1070 - Common Stock - Currency: USD

0.6428  -0.1 (-13.26%)

Premarket: 0.42 -0.22 (-34.66%)

Fundamental Rating

2

FTCH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Specialty Retail industry. FTCH has a bad profitability rating. Also its financial health evaluation is rather negative. FTCH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FTCH had negative earnings in the past year.
In the past year FTCH has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: FTCH reported negative net income in multiple years.
FTCH had negative operating cash flow in 4 of the past 5 years.
FTCH Yearly Net Income VS EBIT VS OCF VS FCFFTCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 1B -1B -2B -3B

1.2 Ratios

The Return On Assets of FTCH (-25.42%) is worse than 83.97% of its industry peers.
With a Return On Equity value of -193.07%, FTCH is not doing good in the industry: 80.15% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -25.42%
ROE -193.07%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-14.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FTCH Yearly ROA, ROE, ROICFTCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K

1.3 Margins

FTCH has a better Gross Margin (42.89%) than 70.23% of its industry peers.
FTCH's Gross Margin has declined in the last couple of years.
FTCH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.65%
GM growth 5Y-3.6%
FTCH Yearly Profit, Operating, Gross MarginsFTCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

FTCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FTCH has been increased compared to 1 year ago.
FTCH has a worse debt/assets ratio than last year.
FTCH Yearly Shares OutstandingFTCH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M
FTCH Yearly Total Debt VS Total AssetsFTCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

2.2 Solvency

FTCH has an Altman-Z score of -0.30. This is a bad value and indicates that FTCH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.30, FTCH is doing worse than 83.21% of the companies in the same industry.
FTCH has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.41, FTCH is not doing good in the industry: 71.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACCN/A
WACC4.98%
FTCH Yearly LT Debt VS Equity VS FCFFTCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M -500M 1B -1B -1.5B

2.3 Liquidity

A Current Ratio of 1.47 indicates that FTCH should not have too much problems paying its short term obligations.
FTCH has a Current ratio (1.47) which is in line with its industry peers.
FTCH has a Quick Ratio of 1.02. This is a normal value and indicates that FTCH is financially healthy and should not expect problems in meeting its short term obligations.
FTCH has a Quick ratio of 1.02. This is in the better half of the industry: FTCH outperforms 72.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.02
FTCH Yearly Current Assets VS Current LiabilitesFTCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for FTCH have decreased strongly by -108.06% in the last year.
The Revenue has been growing slightly by 0.37% in the past year.
FTCH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.11% yearly.
EPS 1Y (TTM)-108.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-204.76%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y31.41%
Revenue growth 5Y43.11%
Sales Q2Q%-1.24%

3.2 Future

FTCH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.33% yearly.
Based on estimates for the next years, FTCH will show a quite strong growth in Revenue. The Revenue will grow by 12.49% on average per year.
EPS Next Y-76.96%
EPS Next 2Y-17.65%
EPS Next 3Y-1.08%
EPS Next 5Y21.33%
Revenue Next Year7.53%
Revenue Next 2Y14.78%
Revenue Next 3Y14.71%
Revenue Next 5Y12.49%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FTCH Yearly Revenue VS EstimatesFTCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
FTCH Yearly EPS VS EstimatesFTCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FTCH. In the last year negative earnings were reported.
Also next year FTCH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FTCH Price Earnings VS Forward Price EarningsFTCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FTCH Per share dataFTCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.65%
EPS Next 3Y-1.08%

More info and screens

0

5. Dividend

5.1 Amount

FTCH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FARFETCH LTD-CLASS A

NYSE:FTCH (12/15/2023, 8:04:00 PM)

Premarket: 0.42 -0.22 (-34.66%)

0.6428

-0.1 (-13.26%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-17 2023-08-17/amc
Earnings (Next)12-28 2023-12-28/amc
Inst Owners0.04%
Inst Owner Change-0.16%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap226.66M
Analysts68.8
Price Target4.59 (614.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.62%
Min EPS beat(2)-49.04%
Max EPS beat(2)64.29%
EPS beat(4)3
Avg EPS beat(4)19.54%
Min EPS beat(4)-49.04%
Max EPS beat(4)64.29%
EPS beat(8)7
Avg EPS beat(8)26.09%
EPS beat(12)9
Avg EPS beat(12)-144.11%
EPS beat(16)11
Avg EPS beat(16)-123.02%
Revenue beat(2)1
Avg Revenue beat(2)-3.6%
Min Revenue beat(2)-13.6%
Max Revenue beat(2)6.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.72%
Min Revenue beat(4)-13.6%
Max Revenue beat(4)6.39%
Revenue beat(8)2
Avg Revenue beat(8)-3.02%
Revenue beat(12)6
Avg Revenue beat(12)0.1%
Revenue beat(16)10
Avg Revenue beat(16)1.7%
PT rev (1m)-8.89%
PT rev (3m)-32.77%
EPS NQ rev (1m)5.81%
EPS NQ rev (3m)6.75%
EPS NY rev (1m)4.21%
EPS NY rev (3m)3.46%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)98831%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.29
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS6.67
BVpS1.31
TBVpS-2.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.42%
ROE -193.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.89%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-14.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.65%
GM growth 5Y-3.6%
F-Score2
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.05%
Cap/Sales 8.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.02
Altman-Z -0.3
F-Score2
WACC4.98%
ROIC/WACCN/A
Cap/Depr(3y)61.75%
Cap/Depr(5y)118.22%
Cap/Sales(3y)7.77%
Cap/Sales(5y)9.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-204.76%
EPS Next Y-76.96%
EPS Next 2Y-17.65%
EPS Next 3Y-1.08%
EPS Next 5Y21.33%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y31.41%
Revenue growth 5Y43.11%
Sales Q2Q%-1.24%
Revenue Next Year7.53%
Revenue Next 2Y14.78%
Revenue Next 3Y14.71%
Revenue Next 5Y12.49%
EBIT growth 1Y-43.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.77%
EBIT Next 3Y34.01%
EBIT Next 5Y25.35%
FCF growth 1Y-44.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.15%
OCF growth 3YN/A
OCF growth 5YN/A